G Protein‐Coupled Receptor 32 Contributes to Inflammation Resolution and Neuronal Excitability Dysfunction in Patients With Focal Cortical Dysplasia IIb and Tuberous Sclerosis Complex
Neuropathology and Applied Neurobiology · 2026
DOI: 10.1111/nan.70062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2026. Verfasst von Kaixuan Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Research Center of PLA, Department of Neurosurgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Focal Cortical Dysplasia, Neurons, Tuberous Sclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Open Cooperation Program from Key Laboratory of Extreme Environmental Medicine, Ministry of Education, National Natural Science Foundation of China, Chongqing graduate student innovation project.
Abstract (Originalsprache)
Background
Focal cortical dysplasia IIb (FCDIIb) and tuberous sclerosis complex (TSC) show persistent neuroinflammation that promotes epileptogenesis and epilepsy progression, suggesting that endogenous resolution of inflammation is inadequate to relieve neuronal network hyperexcitability. G‐protein‐coupled receptor 32 (GPR32) is a key regulator of inflammation resolution and we aimed to explore the roles of GPR32 in cortical lesions of patients with FCDIIb and TSC.
Method
We examined the expression and distribution of GPR32 in patients with FCDIIb and TSC and its effects on human microglial cell activation, inflammation and the electrophysiological properties of neurons.
Results
GPR32 and Resolvin D1 expression was significantly lower in cortical lesions of patients with FCDIIb and TSC than in controls and were negatively correlated with seizure frequency. GPR32 was widely distributed in neurons and microglia and was nearly absent in astrocytes. Furthermore, the Src homology region 2‐containing protein tyrosine phosphatase 2 (SHP2) pathway was downregulated in patients with FCDIIb and TSC. The GPR32/SHP2/nuclear factor‐kappa B pathway inhibited the M1 transformation of microglia to produce numerous pro‐inflammatory mediators and promoted M2 polarisation. GPR32 also regulated neuronal excitability by reducing the amplitude and frequency of spontaneous excitatory postsynaptic currents.
Conclusion
Our results suggest that GPR32 may help control epilepsy in patients with FCDIIb and TSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epilepsy Research Center of PLA, Department of Neurosurgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Department of Neurosurgery, Armed Police Hospital of Chongqing, Chongqing, China.
ORCID-Profile: Zhongke Wang, Shiyong Liu
Förderung
- Open Cooperation Program from Key Laboratory of Extreme Environmental Medicine, Ministry of Education
- National Natural Science Foundation of China
- Chongqing graduate student innovation project
Zitieren
APA
Huang, K., Li, J., He, Z., Li, Y., Liu, X., Wan, Y., Yang, X., Sang, D., Li, S., Wang, Z., & Liu, S. (2026). G Protein‐Coupled Receptor 32 Contributes to Inflammation Resolution and Neuronal Excitability Dysfunction in Patients With Focal Cortical Dysplasia IIb and Tuberous Sclerosis Complex. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.70062
Vancouver
Huang K, Li J, He Z, Li Y, Liu X, Wan Y, et al. G Protein‐Coupled Receptor 32 Contributes to Inflammation Resolution and Neuronal Excitability Dysfunction in Patients With Focal Cortical Dysplasia IIb and Tuberous Sclerosis Complex. Neuropathology and Applied Neurobiology. 2026. doi:10.1111/nan.70062
BibTeX
@article{Huang2026,
author = {Huang, Kaixuan and Li, Jie and He, Zeng and Li, Yang and Liu, Xingye and Wan, Yuhe and Yang, Xiaolin and Sang, Dongxue and Li, Shujing and Wang, Zhongke and Liu, Shiyong},
title = {G Protein‐Coupled Receptor 32 Contributes to Inflammation Resolution and Neuronal Excitability Dysfunction in Patients With Focal Cortical Dysplasia IIb and Tuberous Sclerosis Complex},
journal = {Neuropathology and Applied Neurobiology},
year = {2026},
doi = {10.1111/nan.70062}
}
EUVIMED